BASF's stock rating has been downgraded by UBS from Buy to Neutral due to challenges in achieving earnings growth. The target price has also been reduced from €51 to €48, reflecting lower EBITDA forecasts for 2024 and 2025.

Analysts suggest that the company will face difficulties in the coming year. BASF has recently undergone a strategic shift, redefining its core businesses to include chemicals, materials, industrial solutions, nutrition, and health. As part of this restructuring, the company plans to spin off its environmental catalysts, battery materials, coatings, and agricultural protection segments into independent entities. The aim of this restructuring is to streamline operations and focus on key growth areas.